• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND ENDURANT BIFURCATED STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND ENDURANT BIFURCATED STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number ENBF2816C145E
Medical Device Problem Code Leak/Splash (1354)
Health Effect - Clinical Code Rupture (2208)
Date of Event 03/29/2017
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Event or Problem Description
An endurant stent graft system was implanted in a patient for the endovascular treatment of an abdominal aortic aneurysm.It was reported that the patient presented with a ruptured aneurysm which had previously been treated with an endurant stent graft.The initial ct could not identify the endoleak, but the abdomen had blood throughout.The aneurysm is currently 7 cm in diameter.It was noted that the patient had been stable throughout.An angiogram was then performed and a type ib endoleak was identified in the ipsilateral limb of the endurant stent graft bifurcate.An iliac extension was placed, but was only able to gain an additional 5 mm of seal and the leak persisted.The right hypogastric artery was then coiled and another iliac extension was placed into the right external iliac artery and a leak could no longer be seen.This reportedly resolved the event.The physician stated that the case of the type ib endoleak was due to patient anatomy; specifically, the continued dilation of the iliac artery.The physician stated that the event was not related to the device.No additional clinical sequelae were reported and the patient is fine.
 
Additional Manufacturer Narrative
Corrected information: sex, date of birth.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDURANT BIFURCATED STENT GRAFT
Common Device Name
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
MDR Report Key6509920
Report Number2953200-2017-00647
Device Sequence Number533129
Product Code MIH
UDI-Device Identifier00613994762498
UDI-Public00613994762498
Combination Product (Y/N)N
Initial Reporter StateMN
Initial Reporter CountryUS
PMA/510(K) Number
P100021
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2011
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 03/29/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date08/28/2013
Device Model NumberENBF2816C145E
Device Catalogue NumberENBF2816C145E
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 03/29/2017
Supplement Date Received by Manufacturer03/29/2017
Initial Report FDA Received Date04/20/2017
Supplement Report FDA Received Date10/02/2017
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Life Threatening; Required Intervention;
Patient Age89 YR
-
-